Amyotrophic lateral sclerosis & frontotemporal degeneration

Keyphrases

Publications

2023

Arman Çakar, Emre Pekbilir, Serdar Ceylaner, Hacer Durmuş, Esra Battaloğlu, Umut Şahin, Yeşim Parman
A novel homozygous loss-of-function variant in SOD1 causing progressive spastic tetraplegia and axial hypotonia. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Joseph Boyle, David C Wheeler, Ryan Naum, Paula Burke Brockenbrough, Michelle Gebhardt, LaVon Smith, Tremetris Harrell, Danielle Stewart, Kelly Gwathmey
Analysis of the spatial distribution of amyotrophic lateral sclerosis in Virginia. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Yuyao Sun, Michael Benatar, Javier Mascías Cadavid, Dave Ennist, Paul Wicks, Kim Staats, Morgan Beauchamp, Sartaj Jhooty, Gary Pattee, Andrew Brown, Tulio Bertorini, Paul Barkhaus, Mark Bromberg, Greg Carter, Richard Bedlack, Xiaoyan Li
ALSUntangled #71: Nuedexta. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Ana Rita Henriques, Marta Gromicho, Julian Grosskreutz, Magdalena Kuzma-Kozakiewicz, Susanne Petri, Hilmi Uysal, Susana Pinto, Marília Antunes, Mamede de Carvalho, Ruy M Ribeiro
Association of the practice of contact sports with the development of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
JarosŁaw Dulski, Audrey J Strongosky, Rana Hanna Al-Shaikh, Zbigniew K Wszolek
Expanding the spectrum of KIF5A mutations-case report of a large kindred with familial ALS and overlapping syndrome. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Arman Çakar, Emre Pekbilir, Serdar Ceylaner, Hacer Durmuş, Esra Battaloğlu, Umut Şahin, Yeşim Parman
A novel homozygous loss-of-function variant in SOD1 causing progressive spastic tetraplegia and axial hypotonia. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
James D Berry, Marie Blanchard, Kerina Bonar, Emma Drane, Molly Murton, Uffe Ploug, Kristen Ricchetti-Masterson, Natasa Savic, Emma Worthington, Terry Heiman-Patterson
Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Rup Tandan, Diantha Howard, Dwight E Matthews
Increased total daily energy expenditure in mild to moderate ALS: greater contribution from physical activity energy expenditure than hyper-metabolism. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Christina L Rush, Ethan G Lester, Heena Manglani, Emily Woodworth, Ottavio Vitolo, Maurizio Fava, James D Berry, Kate T Brizzi, Suma Babu, Elizabeth C Lindenberger, J Randall Curtis, Ana-Maria Vranceanu
Resilient together-ALS: leveraging the NDD transdiagnostic framework to develop an early dyadic intervention for people with amyotrophic lateral sclerosis and their informal care-partners. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Gabriela Stegmann, Sherman Charles, Julie Liss, Jeremy Shefner, Seward Rutkove, Visar Berisha
A speech-based prognostic model for dysarthria progression in ALS. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Elisabet Romero-Gangonells, M Núria Virgili-Casas, Mònica Povedano, Maria A Barceló
Clinical and demographical characteristics in a cohort of MND patients treated with riluzole. Differences between tablets and oral suspension. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Barbara Poletti, Edoardo Nicolò Aiello, Antonino La Tona, Federica Solca, Silvia Torre, Eleonora Colombo, Alessio Maranzano, Claudia Morelli, Alberto Doretti, Federico Verde, Alessia Monti, Agostino Brugnera, Angelo Compare, Roberta Ferrucci, Sergio Barbieri, Francesca Mameli, Alberto Priori, Gabriella Pravettoni, Vincenzo Silani, Nicola Ticozzi
Single task-level, 2SD-based cutoffs for the Italian version of the Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Eitan Raveh, Assaf Ben-Shimon, Vova Anisimov, Rivka Kreitman, Edmund Ben-Ami, Elisheva Nechushtan, Nurit Birman, Vivian E Drory
Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Allison A Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, Jennifer Fifita, Lyndal Henden, Ingrid M Keseler, Steven Lenz, Heather Marriott, Emily Mccann, Maysen Mesaros, Sarah Opie-Martin, Emma Owens, Brooke Palus, Justyne Ross, Zhanjun Wang, Hannah White, Ammar Al Chalabi, Peter M Andersen, Michael Benatar, Ian Blair, Johnathan Cooper-Knock, Elizabeth A Harrington, Jeannine Heckmann, John Landers, Cristiane Moreno, Melissa Nel, Evadnie Rampersaud, Jennifer Roggenbuck, Guy Rouleau, Bryan Traynor, Marka Van Blitterswijk, Wouter Van Rheenen, Jan Veldink, Jochen Weishaupt, Luke Drury, Matthew B Harms, Sali M K Farhan, null null
Clinical testing panels for ALS: global distribution, consistency, and challenges. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Thomas P Spargo, Sarah Opie-Martin, Guy P Hunt, Munishikha Kalia, Ahmad Al Khleifat, Simon D Topp, Christopher E Shaw, Ammar Al-Chalabi, Alfredo Iacoangeli, null null
SOD1-ALS-Browser: a web-utility for investigating the clinical phenotype in SOD1 amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Stefan Sennfält, Marco Pagani, Fang Fang, Irina Savitcheva, Ulrika Estenberg, Caroline Ingre
FDG-PET shows weak correlation between focal motor weakness and brain metabolic alterations in ALS. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Alex Berger, Matteo Locatelli, Ximena Arcila-Londono, Ghazala Hayat, Nicholas Olney, James P Wymer, Kelly G Gwathmey, Christian Lunetta, Terry D Heiman-Patterson, Senda Ajroud-Driss, Eric A Macklin, Marie-Abele C Bind, Kimberly Goslin, Tamela Stuchiner, Lauren Brown, Tracy Bazan, Tyler Regan, Ashley Adamo, Valerie Ferment, Carly Schroeder, Megan Somers, Georgios E Manousakis, Kenneth Faulconer, Ervin Sinani, Julia Mirochnick, Hong Yu, Alexander V Sherman, David Walk, null null
The natural history of ALS: Baseline characteristics from a multicenter clinical cohort. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Edward J Kasarskis, Rup Tandan
Why is nutrition vital for advancing ALS care and clinical research? Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Richard J Reimer, Andre Goncalves, Braden Soper, Jose Cadena, Jennifer L Wilson, Amy L Gryshuk, Paola Suarez, Thomas F Osborne, Kevin V Grimes, Priyadip Ray
An electronic health record cohort of Veterans with amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Elisa Canu, Veronica Castelnovo, Paola Mv Rancoita, Michela Leocadi, Alessandra Lamanuzzi, Edoardo Gioele Spinelli, Silvia Basaia, Nilo Riva, Barbara Poletti, Federica Solca, Federico Verde, Nicola Ticozzi, Vincenzo Silani, Sharon Abrahams, Massimo Filippi, Federica Agosta
Italian reference values and brain correlates of verbal fluency index - vs standard verbal fluency test - to assess executive dysfunction in ALS. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Ali Shojaie, Silvia Rota, Ahmad Al Khleifat, K Ray Chaudhuri, Ammar Al Chalabi
Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson's disease. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Jeremy M Shefner, Ammar Al Chalabi, Jinsy A Andrews, Adriano Chio, Mamede de Carvalho, Bettina M Cockroft, Philippe Corcia, Philippe Couratier, Merit E Cudkowicz, Angela Genge, Orla Hardiman, Terry D Heiman-Patterson, Robert D Henderson, Caroline Ingre, Carlayne E Jackson, Wendy Johnston, Noah Lechtzin, Albert C Ludolph, Nicholas J Maragakis, Timothy M Miller, Jesus S Mora, Susanne Petri, Zachary Simmons, Leonard H Van Den Berg, Lorne Zinman, Stuart Kupfer, Fady I Malik, Lisa Meng, Tyrell J Simkins, Jenny Wei, Andrew A Wolff, Stacy A Rudnicki
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Jaime Raymond, Reshma Punjani, Theodore Larson, James D Berry, D Kevin Horton, Paul Mehta
Comparing Amyotrophic lateral sclerosis (ALS) patient characteristics from the National ALS Registry and the Massachusetts ALS Registry, data through 2015. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Jessica Hatch, Paul Barkhaus, Benjamin Barnes, Morgan Beauchamp, Michael Benatar, Tulio Bertorini, Robert Bowser, Mark Bromberg, Andrew Brown, Javier Mascias Cadavid, Gregory T Carter, Nicholas Cole, Jesse Crayle, Mazen Dimachkie, David Ennist, Eva Feldman, Timothy Fullam, Terry Heiman-Patterson, Sartaj Jhooty, Todd Levine, Xiaoyan Li, Isaac Lund, Elise Mallon, Nicholas Maragakis, Christopher J McDermott, Gary Pattee, Kaitlyn Pierce, Dylan Ratner, Kim Staats, Paul Wicks, Martina Wiedau, Richard Bedlack
ALSUntangled #70: caffeine. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Inês Alves, Marta Gromicho, Miguel Oliveira Santos, Susana Pinto, Ana Pronto-Laborinho, Michael Swash, Mamede de Carvalho
Demographic changes in a large motor neuron disease cohort in Portugal: a 27 year experience. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Julia Finsel, Ivar Winroth, Katarzyna Ciećwierska, Olga Helczyk, Erica A Stenberg, Ann-Christin Häggström, Albert C Ludolph, Ingo Uttner, Olof Semb, Beata Pilczuk, Natalia Szejko, Simona Rosentul, Dorothée E Lulé, Magdalena Kuzma-Kozakiewicz, Peter Munch Andersen
Determining impairment in the Swedish, Polish and German ECAS: the importance of adjusting for age and education. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Marta Gromicho, Miguel Oliveira Santos, Susana Pinto, Michael Swash, Mamede de Carvalho
The flail-arm syndrome: the influence of phenotypic features. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Johannes Tröger, Judith Baltes, Ebru Baykara, Elisabeth Kasper, Martha Kring, Nicklas Linz, Jessica Robin, Simona Schäfer, Anja Schneider, Andreas Hermann
PROSA-a multicenter prospective observational study to develop low-burden digital speech biomarkers in ALS and FTD. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Priscilla Tjokrowijoto, Mia Phillips, Amelia Ceslis, Robert D Henderson, Pamela A McCombe, Gail A Robinson
Sensitivity and specificity of the ECAS in identifying executive function and social cognition deficits in MND. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Juliette Foucher, Ivar Winroth, Anikó Lovik, Stefan Sennfält, Joana B Pereira, Fang Fang, Dorothee Lule, Peter M Andersen, Caroline Ingre
Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS). Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Dereje Melka, Hanna Demisse, Hanna Assefa, Yared Zenebe, Biniyam A Ayele, Meron Awraris, Yohannese Gelan, Selam Kifelew, Medina Fedlu, Fikiru Tsehayneh, Mehila Zebenigus, Samson Alemayehu, Heera Tesfaye, Hildana Gulelat, Tsega Guta, Abenet Tafesse, Nebiyu Bekele, Marc Saez, Jan H Veldink, Ammar Al-Chalabi, Monica Povedano, Ahmad Al Khleifat
Epidemiological and clinical profile of amyotrophic lateral sclerosis in Ethiopia: a 5-year multicenter retrospective study. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Eleni Christoforidou, Fabio A Simoes, David Gordon, Kevin Talbot, Majid Hafezparast
Aberrant dynein function promotes TDP-43 aggregation and upregulation of p62 in male mice harboring transgenic human TDP-43. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Allison A Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, Jennifer Fifita, Lyndal Henden, Ingrid M Keseler, Steven Lenz, Heather Marriott, Emily Mccann, Maysen Mesaros, Sarah Opie-Martin, Emma Owens, Brooke Palus, Justyne Ross, Zhanjun Wang, Hannah White, Ammar Al Chalabi, Peter M Andersen, Michael Benatar, Ian Blair, Johnathan Cooper-Knock, Elizabeth A Harrington, Jeannine Heckmann, John Landers, Cristiane Moreno, Melissa Nel, Evadnie Rampersaud, Jennifer Roggenbuck, Guy Rouleau, Bryan Traynor, Marka Van Blitterswijk, Wouter Van Rheenen, Jan Veldink, Jochen Weishaupt, Luke Drury, Matthew B Harms, Sali M K Farhan, null null
Clinical testing panels for ALS: global distribution, consistency, and challenges. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Antonella Casiraghi, Andrea Gentile, Ivan Marjanovic, Adriano Chio
Crushing riluzole tablets: evaluation of loss of powder and active principle in a home-simulation experiment. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Sadegh Ghaderi, Farzad Fatehi, Sanjay Kalra, Seyed Amir Hossein Batouli
MRI biomarkers for memory-related impairment in amyotrophic lateral sclerosis: a systematic review. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Nina Malmström, Birgitta Jakobsson Larsson, Stefan Nilsson, Joakim Öhlén, Ingela Nygren, Peter M Andersen, Anneli Ozanne
Living with a parent with ALS - adolescents' need for professional support from the adolescents' and the parents' perspectives. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Mustafa Çoban, Ugur Bilge, Hale Balseven, HIlmi Uysal, Betül Artut
The economic evaluation of ALS care: quality and cost. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Linda Greensmith, J Barney Bryson
The cholesterol depleting agent, (2-Hydroxypropyl)-ß-cyclodextrin, does not affect disease progression in SOD1 G93A mice. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Christine Zizzi, Danae Alexandrou, Ellen Wagner, Nuran Dilek, John Heatwole, Joanne Wuu, James Caress, Richard Bedlack, Volkan Granit, Jeffrey Statland, Paul Mehta, Michael Benatar, Aaron Kaat, Chad Heatwole
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Peter Bede, Rangariroyashe H Chipika, Ee Ling Tan
Imaging extra-motor dysfunction in motor neuron disease: achievements and controversies. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Timothy Fullam, Carmel Armon, Paul Barkhaus, Benjamin Barnes, Morgan Beauchamp, Michael Benatar, Tulio Bertorini, Robert Bowser, Mark Bromberg, Javier Mascias Cadavid, Gregory T Carter, Mazen Dimachkie, Dave Ennist, Eva L Feldman, Terry Heiman-Patterson, Sartaj Jhooty, Isaac Lund, Christopher J McDermott, Gary Pattee, Dylan Ratner, Paul Wicks, Richard Bedlack
ALSUntangled # 69: astaxanthin. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Paul Mehta, Jaime Raymond, Yuzi Zhang, Reshma Punjani, Moon Han, Theodore Larson, Oleg Muravov, Robert H Lyles, D Kevin Horton
Prevalence of amyotrophic lateral sclerosis in the United States, 2018. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Rüstem Yilmaz, Torsten Grehl, Lukas Eckrich, Ines Marschalkowski, Kanchi Weishaupt, Ivan Valkadinov, Melita Simic, David Brenner, Peter M Andersen, Joachim Wolf, Jochen H Weishaupt
Frequency of C9orf72 and SOD1 mutations in 302 sporadic ALS patients from three German ALS centers. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Sally J Wheelwright, R Maunsell, S Taylor, N Drinkwater, C Erridge, C Foster, M Hardcastle, A Hogden, I Lawson, D Lisiecka, Christopher J McDermott, K E Morrison, C Muir, A Recio-Saucedo, S White
Development of 'gastrostomy tube - is it for me?', a web-based patient decision aid for people living with motor neurone disease considering having a gastrostomy tube placed. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Juan Francisco Vázquez Costa
Do we really need to calculate a minimal important difference for ALSFRS-R?: A letter in response to 'Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R' published in Vol. 24(3-4), pp. 311-316. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Jeremy M Shefner, Bill Jacobsen, Stuart Kupfer, Fady I Malik, Lisa Meng, Jenny Wei, Andrew A Wolff, Stacy A Rudnicki
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Cristian Correa-Arrieta, Fernando Ortiz-Corredor, Sandra Castellar-Leones, Diana Sánchez-Peñarete
Slowly progressive late-onset spinal muscular atrophy Finkel-type related to p.Pro56Ser VABP mutation in Colombia. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Jordi W J Van Unnik, Jaap N E Bakers, Steure Kokx, Leonard H Van Den Berg, Johanna M A Visser-Meily, Anita Beelen, Ruben P A Van Eijk
Portable fixed dynamometry enables home-based, reliable assessment of muscle strength in patients with amyotrophic lateral sclerosis: a pilot study. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Robert McFarlane, Miriam Galvin, Mark Heverin, Éanna Mac Domhnaill, Deirdre Murray, Dara Meldrum, Peter Bede, Anthony Bolger, Lucy Hederman, Sinéad Impey, Gaye Stephens, Ciara O'Meara, Vincent Wade, Ammar Al Chalabi, Adriano Chiò, Phillippe Corcia, Philip van Damme, Caroline Ingre, Christopher J McDermott, Monica Povedanos, Leonard van den Berg, Orla Hardiman
PRECISION ALS-an integrated pan European patient data platform for ALS. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Marion Sommers-Spijkerman, Melinda S Kavanaugh, Esther Kruitwagen-Van Reenen, Aimée Zwarts-Engelbert, Johanna M A Visser-Meily, Anita Beelen
Stigma experienced by ALS/PMA patients and their caregivers: a mixed-methods study. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)